Spontaneous nasal perforation in a bevacizumab‐treated patient with metastatic breast cancer. Issue 6 (27th August 2017)

• Record Type: Journal Article
• Authors: Rodriguez, Cesar A.; Martin, Teresa; Lozano, Rebeca; Gomez, Amalia; Cruz, Juan J.
• Is Part Of: Breast journal. Volume 23:Issue 6(2017:Nov./Dec.)
• Page Start: 745
• Page End: 746
• Publication Date: 2017-08-27
• Subjects: bevacizumab -- breast cancer -- nasal septum perforation; Breast -- Diseases -- Periodicals; Breast -- Cancer -- Periodicals; 618.19
• DOI: 10.1111/tbj.12913
• Languages: English
• ISSNs: 1075-122X

Abstract

Abstract: Nasal septum perforation in patients with cancer receiving systemic therapy is rare, and its association with bevacizumab use has described recently in the literature. Here, we report the case of a 34‐year‐old woman with hormone‐sensitive, HER‐2/ neu negative, metastatic breast cancer who develope a nasal septum perforation during the treatment with paclitaxel and bevacizumab.